United States Cancer Biomarker Testing Market Set for Transformative Growth with Breakthrough Innovations and Expanding Clinical Adoption 2025 | Top key players - Abbott, QIAGEN, Siemens Healthineers AG.

Market Size and Growth:

The Global Cancer Biomarker Testing Market size reached US$ 33.37 Billion in 2024 and is expected to reach US$ 96.53 Billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.

The Cancer Biomarker Testing Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Cancer Biomarker Testing market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/cancer-biomarker-testing-market?sz

The Cancer Biomarker Testing Market refers to the industry focused on diagnostic tests that identify specific genetic, protein, and molecular markers linked to cancer. These tests aid in early detection, prognosis, and personalized treatment selection, driving precision oncology. Market growth is fueled by rising cancer prevalence, technological advancements, and increasing adoption of targeted therapies worldwide.

Recent Key Developments of United States (U.S):

September 2025: Exact Sciences launched Cancerguard, a liquid biopsy test that screens for more than 50 different types of cancer from a single blood sample.

August 2025: The FDA granted accelerated approval to zongertinib for non-squamous non-small cell lung cancer (NSCLC) with HER2 TKD activating mutations and dordaviprone for diffuse midline glioma with an H3 K27M mutation.

July 2025: The FDA granted accelerated approval to sunvozertinib for NSCLC with EGFR exon 20 insertion mutations, and to linvoseltamab-gcpt for relapsed or refractory multiple myeloma.

Late Q2/Early Q3 2025: Guardant Health announced its deep learning-based liquid biopsy assay improved detection rates for early-stage colorectal cancer by 20%.

Ongoing 2025: The integration of Artificial Intelligence (AI) and machine learning in oncology diagnostics is a growing trend, with new platforms and tools being developed to enhance the speed and accuracy of biomarker discovery, validation, and diagnostic applications.

Key Players:

Illumina, Inc.
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Abbott
QIAGEN
Siemens Healthineers AG
Bio-Rad Laboratories, Inc
Agilent Technologies
BioMérieux
Foundation Medicine, Inc.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=cancer-biomarker-testing-market

Market Segmentation:

By Biomarker Type: Genetic Biomarkers, Protein Biomarkers, Others.

By Technology: Omics Technologies, Imaging Technologies, Immunoassays, Next-Generation Sequencing (NGS), PCR-based Techniques, Others.

By Product Type: Instruments, Consumables, Software.

By Application: Diagnostics, Drug Discovery and Development, Therapy Prediction and Monitoring, Personalized and Precision Medicine, Others.

By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Liver Cancer, Melanoma, Blood Cancers, Others.

By End-User: Hospitals, Diagnostic Laboratories, Biopharmaceutical and Biotechnology Companies, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cancer-biomarker-testing-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Cancer Biomarker Testing market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Cancer Biomarker Testing Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Cancer Biomarker Testing market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Cancer Biomarker Testing Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Cancer Biomarker Testing Market in 2025?
◆ What is the projected growth rate of the Cancer Biomarker Testing Market through 2033?
◆ Who are the key players in the Cancer Biomarker Testing Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.